Beacon Pharmaceuticals Limited, the leading oncology company in Bangladesh, has introduced a groundbreaking treatment for lung cancer: Tagrix, the first global generic version of osimertinib.
Learn more
Beacon's groundbreaking export of anticancer drugs from Bangladesh heralds a glorious era for the company and the nation. As the 2nd largest pharmaceutical exporter, Beacon Medicare aims to claim the top spot as Bangladesh's leading medicine exporter. With rapid expansion, innovative products, and steady growth, Beacon is a key player in pharmaceutical exports, specifically in oncology, hepatitis, rheumatic arthritis, and diabetic products, contributing 22.6% to the country's pharmaceutical export sales. Our commitment to manufacturing and exporting life-saving drugs strengthens our position in the healthcare sector.
Let's spread wellness everywhere
